Clivatuzumab MMAE Antibody
Clivatuzumab MMAE is an antibody-drug conjugate (ADC) targeting MUC1 for pancreatic cancer research, delivering the cytotoxic agent MMAE. It is utilized in both in vitro cell-based assays and in vivo xenograft studies to investigate targeted therapy efficacy and mechanisms.
Product Specifications
Product Name Alternative
Anti-MUC1 Reference Antibody
Target
Antibody-Drug Conjugates (ADCs), Mucin
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
9.36 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
145.42 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC400158-500 1x 500 µL
Cytokeratin 17 (E3), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940158-100 1x 100 µL
Cytokeratin 17 (E3), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC401076-500 1x 500 µL
Cytokeratin, HMW (KRTH/1076), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470812-500 1x 500 µL
Tyrosinase (OCA1/812), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details